Our AI Platform offers high-success-rate, easily synthesizable, rapid, and precise early-stage drug development services and high-potential early-stage drug products for small-molecule development needs. Services include disease target and compound screening, structural optimization, cytotoxicity and animal pharmacotoxicology predictions, blood-brain barrier penetration rates, and cell or animal experiment validation. We also provide validated early-stage drug products to enrich R&D projects.
Taipei Medical University (TMU), established in 1960, is a comprehensive university in Taipei focusing on medicine and health sciences. It offers colleges in medicine, pharmacy, dentistry, nursing, and more. TMU is dedicated to advancing medical research, clinical practice, and interdisciplinary collaboration while fostering global engagement and training professional healthcare talents.
Development of an Implantable Bioelectronic Platform for the Peripheral Neuromuscular System Regeneration
Hepatitis B virus detection platforms for novel biomarkers and clinical ap plications
Targeted extracellular vesicle-based therapeutic platform: A nanocarrier for nucleic acid and chemotherapeutic drug delivery
MRI Compatibility Testing and Evaluation Platform for Medical Device and Implants
Technology maturity：Trial production
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
*Organization
*Name
*Phone
*Main Purpose
*Discuss Further
*Job Category
*Overall Rating
*Favorite Area
*Key Tech Focus
*Willing to Receive Updates?
Other Suggestions
Coming soon!